Maxim Mokin1, Swetadri Vasan Setlur Nagesh2, Ciprian N Ionita3, J Mocco4, Adnan H Siddiqui5. 1. Department of Neurosurgery, University of South Florida College of Medicine, Tampa, Florida, USA Department of Neurology, University of South Florida College of Medicine, Tampa, Florida, USA. 2. Department of Biomedical Engineering, University at Buffalo, State University of New York, Buffalo, New York, USA Department of Electrical Engineering, University at Buffalo, State University of New York, Buffalo, New York, USA Department of Mechanical and Aerospace Engineering, University at Buffalo, State University of New York, Buffalo, New York, USA. 3. Department of Biomedical Engineering, University at Buffalo, State University of New York, Buffalo, New York, USA Toshiba Stroke and Vascular Research Center, University at Buffalo, State University of New York, Buffalo, New York, USA. 4. Departments of Neurological Surgery and Radiology and Radiological Sciences, Mount Sinai Health System, New York, New York, USA. 5. Toshiba Stroke and Vascular Research Center, University at Buffalo, State University of New York, Buffalo, New York, USA Departments of Neurosurgery and Radiology, University at Buffalo, State University of New York, Buffalo, New York, USA Jacobs Institute, Buffalo, New York, USA.
Abstract
BACKGROUND: Recently, an in vitro cerebrovascular occlusion model of the intracranial circulation was developed for testing thrombectomy devices. The Cover accessory (Lazarus Effect; Campbell, California, USA) is a novel nitinol braided mesh device that surrounds the stent retrieval device and thrombus during the retrieval process to help prevent clot fragmentation and embolization. METHODS: Using the in vitro model, after introducing fresh clot into the middle cerebral artery, we compared rates of target vessel recanalization and embolization in new territories (areas in which clot had not been introduced) achieved with the Solitaire Flow Restoration (FR) stent retriever (Covidien, Irvine, California) in conjunction with the use of a conventional guide catheter (control group), a balloon guide catheter (BGC group), and the Cover device (Cover group). RESULTS: In a total of 51 thrombectomy experiments (20 in the control group, 20 in the BGC group, and 11 in the Cover group), successful recanalization (Thrombolysis in Cerebral Infarction 2b-3) was achieved more frequently in the Cover group than in the control group or in the BGC group (p=0.047 and p=0.020, respectively). Embolization of new (previously unaffected) territories occurred in five (25%) experiments from the control group and in three (15%) experiments from the BGC group, whereas no embolization of new territories was seen with Cover device assisted thrombectomy. CONCLUSIONS: Application of the Cover device in this experimental model resulted in higher successful recanalization rates, no embolic events, and was more effective than use of the conventional guide catheter or BGC. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
BACKGROUND: Recently, an in vitro cerebrovascular occlusion model of the intracranial circulation was developed for testing thrombectomy devices. The Cover accessory (Lazarus Effect; Campbell, California, USA) is a novel nitinol braided mesh device that surrounds the stent retrieval device and thrombus during the retrieval process to help prevent clot fragmentation and embolization. METHODS: Using the in vitro model, after introducing fresh clot into the middle cerebral artery, we compared rates of target vessel recanalization and embolization in new territories (areas in which clot had not been introduced) achieved with the Solitaire Flow Restoration (FR) stent retriever (Covidien, Irvine, California) in conjunction with the use of a conventional guide catheter (control group), a balloon guide catheter (BGC group), and the Cover device (Cover group). RESULTS: In a total of 51 thrombectomy experiments (20 in the control group, 20 in the BGC group, and 11 in the Cover group), successful recanalization (Thrombolysis in Cerebral Infarction 2b-3) was achieved more frequently in the Cover group than in the control group or in the BGC group (p=0.047 and p=0.020, respectively). Embolization of new (previously unaffected) territories occurred in five (25%) experiments from the control group and in three (15%) experiments from the BGC group, whereas no embolization of new territories was seen with Cover device assisted thrombectomy. CONCLUSIONS: Application of the Cover device in this experimental model resulted in higher successful recanalization rates, no embolic events, and was more effective than use of the conventional guide catheter or BGC. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
Authors: A Sonig; S V Setlur Nagesh; V S Fennell; S Gandhi; L Rangel-Castilla; C N Ionita; K V Snyder; L N Hopkins; D R Bednarek; S Rudin; A H Siddiqui; E I Levy Journal: AJNR Am J Neuroradiol Date: 2018-02-15 Impact factor: 3.825
Authors: Lauren Shepard; Kelsey Sommer; Richard Izzo; Alexander Podgorsak; Michael Wilson; Zaid Said; Frank J Rybicki; Dimitrios Mitsouras; Stephen Rudin; Erin Angel; Ciprian N Ionita Journal: Proc SPIE Int Soc Opt Eng Date: 2017-03-13
Authors: Yang Liu; Mehdi Abbasi; Jorge L Arturo Larco; Ramanathan Kadirvel; David F Kallmes; Waleed Brinjikji; Luis Savastano Journal: J Neurointerv Surg Date: 2021-03-15 Impact factor: 8.572